Results 91 to 100 of about 30,352 (163)

Preclinical evaluation of an mRNA-LNPs vaccine for mucosal protection against dental caries. [PDF]

Front Microbiol
Zhou Y, Shi H, Guo Q, Li Y, Lv L, Hou L, Geng C, Wang D, Yu S, Ma S, Li Y, Sun Z, Li C.   +12 more
europepmc   +1 more source

Associations between declines in uneven terrain walking speed and visuospatial working memory in older adults. [PDF]

Front Aging Neurosci
Hwang J, Liu C, Winesett SP, Fettow T, Shah VA, Chatterjee SA, Manini TM, Hass CJ, Seidler RD, Ferris DP, Roy A, Reuter-Lorenz PA, Clark DJ.   +12 more
europepmc   +1 more source

Correction: RNA and protein immunization with <i>Trypanosoma cruzi</i> trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. [PDF]

Front Cell Infect Microbiol
Dos Santos NSA, de Almeida-Júnior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, de Melo Oliveira NF, Gazzinelli RT, Machado FS, Teixeira SMR.   +14 more
europepmc   +1 more source

MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responses. [PDF]

Front Immunol
Rambichler S, Kassub R, Carrasco-León R, Lämmermann K, Feigl M, Bathke B, Durand C, Fras Ž, Heiseke A, Riedl A, Koppius A, Brod F, Suter M, Hausmann J, Medina-Echeverz J, Chaplin P, Hochrein H, Hinterberger M.   +17 more
europepmc   +1 more source

Intranasal BCG vaccination induces systemic and pulmonary mucosal immune responses against tuberculosis in a goat model. [PDF]

Front Immunol
Cuenca-Lara P, Blay-Benach M, Cervera Z, Moraleda J, Sevilla IA, Garrido JM, Singh M, López-Soria S, Vidal E, Domingo M, Pérez de Val B.   +10 more
europepmc   +1 more source

Immunogenicity and protection of octavalent influenza vaccine candidates using adjuvanted proteins or mRNA-LNPs in naïve mice. [PDF]

NPJ Vaccines
Catani JPP, Smet A, Ysenbaert T, Amelinck L, Sedeyn K, Saelens X, Vogel TU.   +6 more
europepmc   +1 more source

Macrophage anti-bacterial activity is controlled by adenylate kinase 4-mediated mitochondrial DNA synthesis. [PDF]

J Exp Med
Chin WY, Wu CT, Liou GG, Jiang ST, Cheng YS, Lin JS, Wu-Hsieh BA, Miaw SC.   +7 more
europepmc   +1 more source

Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice. [PDF]

Front Immunol
Reguzova A, Haug V, Metz C, Müller M, Fandrich M, Dulovic A, Amann R.   +6 more
europepmc   +1 more source

Durable humoral immunity and long-term protection induced by a Crimean-Congo hemorrhagic fever virus replicon particle vaccine in mice. [PDF]

NPJ Vaccines
Sorvillo TE, Karaaslan E, Davies KA, Welch SR, Scholte FEM, Coleman-McCray JD, Aida-Ficken V, Pegan SD, Bergeron É, Montgomery JM, Spiropoulou CF, Spengler JR.   +11 more
europepmc   +1 more source

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. [PDF]

Front Immunol
Kerth HA, Kächele M, Müller N, Singh S, Tulessin M, Sacherl J, Ates Öz E, Su J, Bester R, Miko S, Steiger K, Mogler C, Busch DH, Wettengel JM, Protzer U, Kosinska AD.   +15 more
europepmc   +1 more source